Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 28

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 28
---
 Clinical       
 Research       
 Committee      |
| Michael Giuffre, M.D.      |           | Chair        | ●             | ●              |
| Richard Kuntz, M.D., M.Sc. |           | ●            |               | Chair          |
| Tanya Lewis                |           | ●            | ●             | ●              |
| Daniel O’Connor            | ●         |              | ●             |                |
| James Parsons              | Chair     |              |               |                |
| Rick Pauls                 |           |              |               |                |
| Richard Pilnik             | ●         |              | Chair         |                |
| Charles Semba, M.D.        | ●         | ●            |               | ●              |

Audit Committee

Responsibilities. The Audit Committee assists the Board of Directors in fulfilling its oversight responsibilities relating to our annual and quarterly financial statements filed with the SEC and any applicable securities regulatory authorities of the provinces and territories of Canada, our financial reporting process, our internal control over financial accounting and disclosure controls and procedures, the annual independent audit of our financial statements and the effectiveness of our legal compliance and ethics programs. The Audit Committee’s primary responsibilities include:

| ● | overseeing our financial reporting process, internal control over financial reporting and disclosure controls and procedures on behalf of the Board of Directors; |

| ● | having sole authority to appoint, oversee, evaluate, retain and terminate the engagement of our independent registered public accounting firm and establish the compensation to be paid to the firm; |

| ● | reviewing and pre-approving all audit services and permissible non-audit services to be provided to us by our independent registered public accounting firm; |

| ● | establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or auditing matters and for the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters; and |

| ● | overseeing our systems to monitor legal and ethical compliance programs, including the establishment and administration of (including the grant of any waiver from) a written code of ethics applicable to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. |

<div align='center'>25</div>

In addition to its primary responsibilities, the Audit Committee oversees DiaMedica’s systems to monitor compliance with legal and regulatory requirements, our Code of Business Conduct and Ethics, and our cybersecurity efforts.

The Audit Committee has the authority to engage the services of outside experts and advisors as it deems necessary or appropriate to carry out its